CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Conditions:   Acute Myeloid Leukemia;   Myeloid Neoplasm Interventions:   Drug: Liposome-encapsulated Daunorubicin-Cytarabine;   Drug: Cladribine;   Drug: Cytarabine;   Biological: Granulocyte Colony-Stimulating Factor;   Drug: Mitoxantrone;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials